In 2024, and as of 31 of January, approximately 10 000 CHIKVD cases and no deaths have been reported worldwide. A total of eight countries reported CHIKVD cases from the America (6) and Asia (2).
This course focuses on antimicrobial stewardship as an approach to address healthcare-associated infections (HAI) resulting from multi-drug resistance organisms in acute care settings.
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 21-27 January 2024 and includes updates on SARS-CoV-2, influenza, cholera, chikungunya, dengue and zika.
More frequent heatwaves and flooding, longer and hotter summers - all of these factors created more favourable conditions for mosquitos to thrive. Watch our animation, learn more and stay safe!
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 December 2023 and includes updates on measles, chikungunya, dengue, SARS-CoV-2, diphtheria, West Nile virus, respiratory virus epidemiology and influenza.
Mumps is a viral infection first described by Hippocrates that in its classical form causes acute parotitis and, less frequently, orchitis, meningitis and pneumonia.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5 - 11 November 2023 and includes updates on SARS-CoV-2 variants, an overview of respiratory virus epidemiology in the EU/EEA, West Nile Virus, measles, diphtheria, Middle East respiratory virus syndrome, chikungunya, and dengue.
In 2021, 1 567 cases of mumps were reported to ECDC by 27 European Union/European Economic Area(EU/EEA) Member States, with an overall notification rate of 0.4 cases per 100 000 population. This wassignificantly lower than the notification rates reported during the previous four years (range 1.7-4.2).